UINF:XETRA:XETRA-Lyxor US$ 10Y Inflation Expectations UCITS ETF - C-USD (EUR)

ETF | Others |

Last Closing

USD 126.275

Change

-1.24 (-0.97)%

Market Cap

N/A

Volume

1.05K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.62 (+1.33%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.24 (+0.23%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.25 (+1.04%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.16 (+1.20%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.07 (+1.24%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.20 (+0.84%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

N/A

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.30 (+0.55%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.09 (+0.89%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.16 (-0.13%)

USD 12.26B

ETFs Containing UINF:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.35% 33% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.35% 33% F 32% F
Trailing 12 Months  
Capital Gain 8.87% 47% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.87% 47% F 48% F
Trailing 5 Years  
Capital Gain 38.75% 50% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.75% 50% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain 8.57% 57% F 57% F
Dividend Return 8.57% 56% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.42% 69% C- 75% C
Risk Adjusted Return 101.70% 86% B+ 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike